Intrauterine

Reduce adhesion formation following intrauterine surgery

Even with the best surgical technique, adhesions can form in the uterus following a variety of common procedures—from dilation and curettage to myomectomy, adhesiolysis, and other hysteroscopic surgeries. Intrauterine (IU) adhesions can cause a variety of complications, from pain and menstrual cycle abnormalities to infertility or inability to carry pregnancy to term. Reduce intrauterine adhesion formation with Intercoat® IU Adhesion Barrier Gel from Fziomed.

Intercoat IU Adhesion Barrier Gel for intrauterine use (also sold under the brand name Oxiplex/IU®) provides a temporary, protective separation of tissues during the body’s natural healing process, reducing adhesion formation.

Preserve surgical excellence – Improve patient outcomes

Product Overview Reduced Infertility Risk and Improved Outcomes Safety and Efficacy Ease of Use Patient Satisfaction Stability

Product Overview

Intercoat IU is intended for use as an adjunct to intrauterine procedures for reducing the incidence, extent, and severity of adhesions.

Intercoat IU gel is supplied sterile, ready to use in a 10mL syringe with an applicator designed specifically for intrauterine use.

Reduced Infertility Risk and Improved Outcomes

A randomized clinical study showed that patients treated with Intercoat IU Adhesion Barrier Gel demonstrated fewer de novo adhesions and improved patency of the Fallopian tube and uterine ostia.¹ A second clinical study showed patients treated with Intercoat IU Adhesion Barrier Gel had fewer moderate to severe adhesions and an improved fertility rate.²

Safety and Efficacy

Our patented dual-polymer formulation combines two biocompatible synthetic polymers proven safe and effective over more than two decades of worldwide use. Intercoat IU Adhesion Barrier Gel is absorbable, and contains no pharmaceutical agents or materials of human, animal, or bacterial origin.

Ease of Use

Intercoat IU is provided sterile, ready to use, and requires no mixing or special handling or storage conditions. The prepackaged, smooth, rounded tip applicator allows for safe insertion and ease of application while the clear absorbable gel maintains local visibility.

Patient Satisfaction

Reducing postoperative pain and adhesiogenic complications can lead to improved reproductive health and patient satisfaction, minimizing potential risks in future operations and patient complaints.

Stability

Intercoat IU gel’s unique viscosity is flowable yet remains where applied with no change in volume that could adversely affect nearby tissues.

Download the instructions for use

Connect with Fziomed

References

Di Spiezio, Sardo, et al. Efficacy of a polyethylene oxide-sodium carboxymethylcellulose gel in prevention of uterine adhesions after hysteroscopic surgery. JMIG. 2011(Apr);18(4):462-9.
Fuchs N, Smorgick N, et al. Intercoat (Oxiplex/AP Gel) for preventing intrauterine adhesions after operative hysteroscopy for suspected retained products of conception: double-blind, prospective, randomized pilot study. JMIG. 2013(July);21(1):126-130.

Fziomed, Inc.
231 Bonetti Drive
San Luis Obispo, CA 93401
USA
Phone: +1 (805) 546-0610
Fax: +1 (805) 546-0571
Email: [email protected]

Fziomed products are not currently available in the United States.

The following trademarks are owned by Fziomed, Inc. and registered in the United States and certain foreign jurisdictions: FZIOMED®, OXIPLEX®, OXIPLEX/SP®, DYNAVISC®, INTERPOSE®, INTERCOAT®, OXIPLEX/AP®, and OXIPLEX/IU®.

Website design RainCastle Communications.